08:14 AM EDT, 09/04/2024 (MT Newswires) -- Kits Eyecare ( KTYCF ) said on Wednesday it expects third-quarter revenue to exceed the previously guided range of $39 million to $41 million and will exceed 32% growth rate year-over-year.

The revision follows a record-breaking week of ordered sales of $3.5 million for the week ending August 31.

Outlook for adjusted EBITDA as a percentage of revenue remains between 3% and 5%, the company said.